Elena Marsh – HERE Hilton Head

FDA withdraws Krazati Erbitux colorectal approval

The Food and Drug Administration has withdrawn the accelerated approval of Krazati (adagrasib) in combination with Erbitux (cetuximab) for adults with KRAS G12C-mutated locally advanced or metastatic colorectal\u2026

Sep 9, 2026

Health

Abbott TactiFlex Duo ablation catheter approved

The Food and Drug Administration approved Abbott's TactiFlex Duo Ablation Catheter, Sensor Enabled, a device that combines pulsed-field ablation and radiofrequency energy in a single catheter to treat\u2026

Sep 9, 2026

Health

FDA approves Etcamah for ESR1 breast cancer

The Food and Drug Administration on September 4, 2026 granted accelerated approval to Etcamah (camizestrant) in combination with a CDK4/6 inhibitor for adults with hormone-receptor-positive, HER2-negative locally advanced\u2026

Sep 9, 2026

Health

Kofinas garlic olive oil recalled by FDA

LMSI LLC, doing business as Kofinas Olive Oil, is voluntarily recalling its Garlic Mediterranean Infused Extra Virgin Olive Oil because the product contains a garlic essential oil that\u2026

Sep 9, 2026

Health

FDA approves RASONQUE for pancreatic cancer

The Food and Drug Administration approved RASONQUE (daraxonrasib), the first targeted therapy in a new class of RAS inhibitors, for adults with metastatic pancreatic adenocarcinoma who have already\u2026

Sep 9, 2026

Health

HHS names four permanent senior FDA leaders

The Department of Health and Human Services on September 8, 2026, named four permanent senior leaders at the Food and Drug Administration, filling the top posts at the\u2026

Sep 9, 2026

Stories by Elena Marsh

Recent stories

FDA withdraws Krazati Erbitux colorectal approval

Abbott TactiFlex Duo ablation catheter approved

FDA approves Etcamah for ESR1 breast cancer

Kofinas garlic olive oil recalled by FDA

FDA approves RASONQUE for pancreatic cancer

HHS names four permanent senior FDA leaders